Skip to main content
. 2023 Jul 11;14:1206872. doi: 10.3389/fmicb.2023.1206872

Table 4.

Theoretical ADMET data analysis.

Sl. No. Absorption Distribution Metabolism Excretion Toxicity
Water solubility Log S Caco-2 permeability × 10−6 Human intestinal absorption (%) VDss (human) BBB permeability CYP450 1A2 inhibitor CYP450 2D6 substrate Total clearance (ml/min/kg) Renal OCT2 substrate Max. tolerated the dose (log mg/kg/day) Skin sensitization Hepatotoxicity
01 −3.71 1.226 93.70 0.327 0.470 Yes No 0.355 No 0.051 No Yes
02 −4.193 1.08 95.43 0.402 0.274 Yes No 0.468 No −0.436 No Yes
03 −4.881 1.054 94.24 0.371 0.437 Yes No 0.156 No 0.473 No Yes
04 −4.807 1.053 94.53 0.378 0.424 Yes No 0.217 No 0.467 No Yes
05 −5.064 1.3 96.56 −0.243 −0.013 Yes No 0.213 No 0.193 No Yes
06 −3.609 0.882 94.96 0.188 0.398 Yes No 0.360 No −0.046 No Yes
07 −3.71 1.226 93.70 0.327 0.470 Yes No 0.355 No 0.051 No Yes
08 −3.607 1.519 93.27 0.915 0.373 Yes Yes 1.123 No 0.276 No Yes
09 −4.421 1.147 96.34 −0.134 0.173 Yes No 0.132 No 0.514 No Yes
10 −3.836 0.454 60.16 −0.744 −1.876 No No −0.117 No 0.568 No Yes